LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the launch ...

Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.

The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...

A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan ...

The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...